Hong Kong, China
United States
Overview
Top Gainers
Top Losers
Most Active
Top Industries
Most Popular ETFs
Calendar
IPO
52 Week High/Low
Stock Earnings

Biotechnology & Medical Research

No.
Symbol/Name
Spark Chart
% Change
Last Price
High
Low
Volume
% Range
P/E
Market Cap
1

H

Hookipa Pharma

HOOK

+38.95%
1.320
1.395
0.9787
1.29M
43.68%
-0.3805
15.92M
2

T

Transcode Therapeutics Inc

RNAZ

+38.71%
0.5640
0.7867
0.4636
130.34M
77.82%
-0.0120
13.16M
3

R

Regencell Bioscience Holdings Ltd

RGC

+28.33%
77.00
81.40
54.00
169.36K
44.25%
-232.9099
1.00B
4

T

Taysha Gene Therapies, Inc.

TSHA

+24.23%
2.410
2.430
1.930
6.69M
25.77%
-6.7507
494.18M
5

V

Vigil Neuroscience, Inc.

VIGL

+21.90%
2.560
2.710
2.110
497.91K
28.57%
-1.2356
119.48M
6

L

Lexeo Therapeutics Inc

LXEO

+19.85%
4.710
5.00
3.880
1.34M
27.99%
-1.5225
156.36M
7

E

Endra Life Sciences Inc

NDRA

+19.80%
7.20
7.50
6.02
141.20K
24.63%
-0.1265
4.05M
8

I

Immunic Inc

IMUX

+18.17%
1.170
1.190
1.000
2.42M
19.19%
-1.1662
112.11M
9

C

Curis

CRIS

+17.54%
2.480
2.700
2.170
269.43K
25.11%
-0.3604
25.95M
10

G

Geovax Labs Inc

GOVXW

+17.28%
0.0353
0.0354
0.0327
2.81K
8.97%
-0.0073
--
11

C

CervoMed

CRVO

+16.56%
10.56
11.25
8.96
1.26M
25.28%
-5.2332
91.90M
12

M

Maze Therapeutics

MAZE

+14.49%
10.59
10.81
9.11
182.75K
18.38%
136.1183
453.54M
13

S

Sagimet Biosciences Inc.

SGMT

+13.91%
3.930
4.040
3.400
677.47K
18.55%
-2.7038
126.53M
14

F

Fulcrum Therapeutics

FULC

+13.77%
4.380
4.690
3.730
926.65K
23.64%
-27.9159
236.43M
15

A

Adial Pharmaceuticals Inc

ADIL

+13.04%
0.7800
0.8550
0.6505
7.02M
29.64%
-0.2867
5.13M
16

G

Gh Research Plc

GHRS

+12.89%
10.77
10.85
9.47
199.58K
14.47%
-14.3830
668.04M
17

L

Longevity Health

XAGE

+12.50%
0.1755
0.1849
0.1531
4.09M
20.38%
-0.3616
5.29M
18

C

Conduit Pharmaceuticals

CDTTW

+11.84%
0.0085
0.0100
0.0071
50.57K
38.16%
-0.0004
--
19

B

Blueprint Medicines Corp

BPMC

+10.89%
99.25
99.78
90.02
1.72M
10.91%
-92.9917
6.41B
20

S

Silexion Therapeutics Corp

SLXNW

+10.71%
0.0620
0.0620
0.0500
10.33K
21.43%
-0.0069
--
21

A

Affimed

AFMD

+10.55%
1.100
1.130
0.9900
176.54K
14.07%
-0.2162
18.03M
22

E

Envveno Medical Corporation

NVNO

+10.33%
3.310
3.370
3.021
108.73K
12.00%
-2.6006
58.04M
23

S

Solid Bioscience

SLDB

+10.27%
3.650
3.695
3.215
1.46M
14.50%
-1.1948
282.85M
24

K

Klotho Neurosciences, Inc.

KLTO

+10.12%
0.1817
0.2000
0.1610
651.62K
23.64%
-0.5687
5.18M
25

A

Addex Therapeutics Ltd

ADXN

+10.01%
8.57
8.57
8.57
842
0.93%
1.1926
9.16M
26

C

Channel Therapeutics Corporation

CHRO

+9.65%
1.250
1.275
1.060
71.23K
18.85%
-0.8759
7.63M
27

K

Kazia Therapeuti

KZIA

+9.47%
3.930
3.940
3.690
68.00K
6.96%
-0.0232
5.34M
28

S

Shattuck Labs, Inc.

STTK

+9.20%
1.080
1.115
0.9524
181.57K
16.44%
-0.7269
51.73M
29

P

Palatin Tech

PTN

+9.00%
0.2180
0.2200
0.1901
1.34M
14.95%
-0.1416
5.67M
30

I

Inflarx

IFRX

+8.82%
1.850
1.890
1.700
408.92K
11.18%
-2.2741
124.20M
31

A

Adlai Nortye Ltd.

ANL

+8.70%
2.000
2.000
2.000
374
7.07%
-1.8925
73.80M
32

C

Cosciens Biopharma

CSCI

+8.70%
3.750
3.750
3.500
2.61K
10.72%
-0.6323
11.80M
33

X

Xtl Biopharmaceu

XTLB

+8.51%
1.530
1.740
1.400
23.83K
19.50%
-9.0426
13.49M
34

R

Relmada Therapeutics Inc

RLMD

+8.47%
0.3497
0.3750
0.3200
2.14M
17.06%
-0.1319
11.61M
35

P

Protagenic Therapeutics Inc

PTIX

+8.44%
0.2429
0.2497
0.2240
371.76K
11.52%
-0.2154
1.83M
36

I

Immuneering Corp

IMRX

+8.40%
1.290
1.300
1.210
256.46K
7.56%
-0.6337
46.42M
37

S

Silence Therapeutics Plc

SLN

+8.38%
4.010
4.090
3.690
238.01K
10.80%
-4.0935
189.37M
38

B

Bluejay Diagnostics Inc

BJDX

+8.38%
2.070
2.080
1.870
3.64M
10.99%
-0.0181
3.09M
39

A

ACLARION INC

ACONW

+8.30%
0.0339
0.0339
0.0312
1.51K
8.63%
-0.0000
--
40

A

Aligos Therapeutics, Inc.

ALGS

+8.15%
6.04
6.32
5.46
124.71K
15.36%
-0.2881
36.90M
41

C

Cogent Biosciences Inc

COGT

+8.06%
5.63
5.64
5.06
1.28M
11.23%
-2.9030
641.01M
42

C

Capstone Holding Corp.

CAPS

+7.95%
1.900
1.950
1.820
12.89K
7.39%
-0.0498
9.86M
43

L

Larimar Therapeutics Inc

LRMR

+7.92%
2.860
2.860
2.521
3.09M
12.81%
-2.1734
183.12M
44

T

Terns Pharmaceuticals, Inc.

TERN

+7.88%
3.560
3.580
3.315
1.24M
8.03%
-3.1857
310.92M
45

L

Lipocine Inc

LPCN

+7.55%
3.560
3.560
3.360
10.22K
6.05%
2,373.3333
19.05M
46

M

MBX Biosciences Inc

MBX

+7.53%
11.28
11.36
10.07
277.06K
12.29%
-1.9388
377.03M
47

T

Tenaya Therapeutics, Inc.

TNYA

+7.37%
0.5100
0.5100
0.4621
1.70M
9.83%
-0.3893
82.94M
48

S

Sionna Therapeutics

SION

+7.23%
12.90
12.90
11.67
245.62K
10.22%
-9.2275
548.52M
49

G

Galecto Inc.

GLTO

+7.14%
3.000
3.060
2.870
45.31K
9.29%
-0.1619
3.97M
50

G

GRI Bio

GRI

+7.14%
1.950
2.070
1.796
187.86K
13.90%
-0.0353
1.02M

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.